Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

NCT02974348 is registered in ClinicalTrials.gov with University of Bamenda as lead sponsor.

NCT NCT02974348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02974348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
Lead sponsor
University of Bamenda
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
October 31, 2014
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistant malaria due to plasmodium falciparum